日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2(+) breast cancer: TBCRC049 phase 2 study results

Tucatinib-trastuzumab-capecitabine治疗HER2(+)乳腺癌女性软脑膜转移:TBCRC049 II期研究结果

Murthy, Rashmi K; O'Brien, Barbara J; Berry, Donald A; Singareeka-Raghavendra, Akshara; Monroe, Maria Gule; Johnson, Jason; White, Jason; Schwartz-Gomez, Jill; Topletz-Erickson, Ariel; Lobbous, Mina; Riley, Kristen; Melisko, Michelle; Morikawa, Aki; Ferguson, Sherise D; de Groot, John F; Krop, Ian E; Valero, Vicente; Rimawi, Mothaffar F; Wolff, Antonio C; Tripathy, Debu; Lin, Nancy U; Stringer-Reasor, Erica M

Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030)

视觉和计算机评估的肿瘤浸润淋巴细胞在早期三阴性乳腺癌中的预后价值(TBCRC-030)

Nader-Marta, Guilherme; Chu, Xiangying; Mukhopadhyay, Satabhisa; Abramson, Vandana G; Brufsky, Adam; Stringer-Reasor, Erica Michelle; Dent, Susan Faye; Traina, Tiffany A; Carey, Lisa A; Rimawi, Mothaffar F; Specht, Jennifer M; Miller, Kathy D; Santa-Maria, Cesar Augusto; Dasgupta, Tathagata; Kurt, Busem Binboğa; DeMeo, Michelle; Krop, Ian E; Tung, Nadine M; Schnitt, Stuart J; Tayob, Nabihah; Mayer, Erica L

Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNA

从无细胞DNA中检测酪氨酸激酶抑制剂的异质性耐药机制

Parsons, Heather A; Messer, Conor; Santos, Katheryn; Weiss, Jakob; Merrell, David; Danysh, Brian P; Hughes, Melissa E; Kirkner, Gregory J; Patel, Ashka; Hess, Julian; Sendrick, Kerry; Stewart, Chip; Grant, Elizabeth; Schlueter-Kuck, Kristy; Grinshpun, Albert; Wagle, Nikhil; Veeraraghavan, Jamunarani; Leone, Jose Pablo; Freedman, Rachel A; Metzger, Otto; Schiff, Rachel; Winer, Eric P; Tolaney, Sara M; Rimawi, Mothaffar; Krop, Ian E; Getz, Gad; Lin, Nancy U

A composite (18)F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)

一种基于 (18)F-FDG PET/CT 和 HER2 组织的复合生物标志物,用于预测 HER2 阳性乳腺癌对新辅助帕妥珠单抗和曲妥珠单抗的反应 (TBCRC026)

Hennessy, Maeve A; Cimino-Mathews, Ashley; Carter, Jodi M; Kachergus, Jennifer M; Ma, Yaohua; Leal, Jeffrey P; Solnes, Lilja B; Abramson, Vandana G; Carey, Lisa A; Rimawi, Mothaffar; Specht, Jennifer; Storniolo, Anna Maria; Vaklavas, Christos; Krop, Ian; Winer, Eric; Denbow, Rita; Valero, Vincente; Wolff, Antonio C; Wahl, Richard L; Huang, Chiung-Yu; Stearns, Vered; Thompson, E Aubrey; Connolly, Roisin M

Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response

对 HER2 阳性乳腺肿瘤进行多重空间蛋白质组学分析,揭示与治疗反应相关的独特分子和免疫学特征

Maeve A Hennessy ,Ashley Cimino-Mathews ,Jodi M Carter ,Jennifer M Kachergus ,Yaohua Ma ,Jeffrey P Leal ,Lilja B Solnes ,Rita Denbow ,Vandana G Abramson ,Lisa A Carey ,Mothaffar Rimawi ,Jennifer Specht ,Anna Maria Storniolo ,Vicente Valero ,Christos Vaklavas ,Eric P Winer ,Ian E Krop ,Antonio C Wolff ,Richard L Wahl ,Edith A Perez ,Chiung-Yu Huang ,Vered Stearns ,E Aubrey Thompson ,Roisin M Connolly

Real-World Evidence Acceptability and Use in Breast Cancer Treatment Decision-Making in the United States: Call-to-Action from a Multidisciplinary Think Tank

美国乳腺癌治疗决策中真实世界证据的可接受性和应用:来自多学科智库的行动呼吁

Khozin, Sean; Dreyer, Nancy A; Galante, Dominic; Liu, Raymond; Neumann, Peter; Nussbaum, Nathan; O'Shaughnessy, Joyce; Patt, Debra; Rimawi, Mothaffar; Rugo, Hope; Tolaney, Sara M; Weiss, Marisa; Brufsky, Adam

Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses.

源自患者的三阴性乳腺癌异种移植模型能够对化疗反应进行解卷积和预测

Lei Jonathan T, Dobrolecki Lacey E, Huang Chen, Srinivasan Ramakrishnan R, Vasaikar Suhas V, Lewis Alaina N, Sallas Christina, Zhao Na, Cao Jin, Landua John D, Moon Chang In, Liao Yuxing, Hilsenbeck Susan G, Osborne C Kent, Rimawi Mothaffar F, Ellis Matthew J, Petrosyan Varduhi, Wen Bo, Li Kai, Saltzman Alexander B, Jain Antrix, Malovannaya Anna, Wulf Gerburg M, Marangoni Elisabetta, Li Shunqiang, Kraushaar Daniel C, Wang Tao, Damodaran Senthil, Zheng Xiaofeng, Meric-Bernstam Funda, Echeverria Gloria V, Anurag Meenakshi, Chen Xi, Welm Bryan E, Welm Alana L, Zhang Bing, Lewis Michael T

IRE1α silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer

IRE1α通过沉默dsRNA来阻止紫杉烷类药物诱导的三阴性乳腺癌细胞焦亡

Longyong Xu ,Fanglue Peng ,Qin Luo ,Yao Ding ,Fei Yuan ,Liting Zheng ,Wei He ,Sophie S Zhang ,Xin Fu ,Jin Liu ,Ayse Sena Mutlu ,Shuyue Wang ,Ralf Bernd Nehring ,Xingyu Li ,Qianzi Tang ,Catherine Li ,Xiangdong Lv ,Lacey E Dobrolecki ,Weijie Zhang ,Dong Han ,Na Zhao ,Eric Jaehnig ,Jingyi Wang ,Weiche Wu ,Davis A Graham ,Yumei Li ,Rui Chen ,Weiyi Peng ,Yiwen Chen ,Andre Catic ,Zhibin Zhang ,Bing Zhang ,Anthony M Mustoe ,Albert C Koong ,George Miles ,Michael T Lewis ,Meng C Wang ,Susan M Rosenberg ,Bert W O'Malley ,Thomas F Westbrook ,Han Xu ,Xiang H-F Zhang ,C Kent Osborne ,Jin Billy Li ,Matthew J Ellis ,Mothaffar F Rimawi ,Jeffrey M Rosen ,Xi Chen

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT

辅助曲妥珠单抗-美坦新与紫杉醇联合曲妥珠单抗治疗I期人表皮生长因子受体2阳性乳腺癌:ATEMPT研究的5年结果及相关性分析

Tarantino, Paolo; Tayob, Nabihah; Villacampa, Guillermo; Dang, Chau; Yardley, Denise A; Isakoff, Steven J; Valero, Vicente; Faggen, Meredith; Mulvey, Therese; Bose, Ron; Weckstein, Douglas; Wolff, Antonio C; Reeder-Hayes, Katherine; Rugo, Hope S; Ramaswamy, Bhuvaneswari; Zuckerman, Dan; Hart, Lowell; Gadi, Vijayakrishna K; Constantine, Michael; Cheng, Kit; Garrett, Audrey Merrill; Marcom, P Kelly; Albain, Kathy; DeFusco, Patricia; Tung, Nadine; Ardman, Blair; Nanda, Rita; Jankowitz, Rachel C; Rimawi, Mothaffar; Abramson, Vandana; Pohlmann, Paula R; Van Poznak, Catherine; Forero-Torres, Andres; Liu, Minetta C; Ruddy, Kathryn J; Waks, Adrienne G; DeMeo, Michelle; Burstein, Harold J; Partridge, Ann H; Dell'Orto, Patrizia; Russo, Leila; Krause, Emma; Newhouse, Daniel J; Kurt, Busem Binboğa; Mittendorf, Elizabeth A; Schneider, Bryan; Prat, Aleix; Winer, Eric P; Krop, Ian E; Tolaney, Sara M

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial

接受新辅助阿那曲唑、氟维司群或二者联合治疗的雌激素受体丰富/ERBB2阴性绝经后乳腺癌患者的内分泌敏感性疾病发生率:一项3期随机临床试验

Ma, Cynthia X; Suman, Vera J; Sanati, Souzan; Vij, Kiran; Anurag, Meenakshi; Leitch, A Marilyn; Unzeitig, Gary W; Hoog, Jeremy; Fernandez-Martinez, Aranzazu; Fan, Cheng; Gibbs, Richard A; Watson, Mark A; Dockter, Travis J; Hahn, Olwen; Guenther, Joseph M; Caudle, Abigail; Crouch, Erika; Tiersten, Amy; Mita, Monica; Razaq, Wajeeha; Hieken, Tina J; Wang, Yang; Rimawi, Mothaffar F; Weiss, Anna; Winer, Eric P; Hunt, Kelly K; Perou, Charles M; Ellis, Matthew J; Partridge, Ann H; Carey, Lisa A